Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 85 Lymphoma 58 Lymphoma, Large B-Cell, Diffuse 55 Lymphoma, Non-Hodgkin 34 Osteosarcoma 30 Precursor Cell Lymphoblastic Leukemia-Lymphoma 25 Hodgkin Disease 25 Burkitt Lymphoma 24 Testicular Neoplasms 22 Neuroectodermal Tumors, Primitive, Peripheral 19 Ovarian Neoplasms 18 Leukemia 18 Lymphoma, Follicular 17 Fibrosarcoma 16 Testicular Germ Cell Tumor 15 Neuroblastoma 15 Teratoma 14 Rhabdomyosarcoma 14 Lymphoma, Large-Cell, Immunoblastic 14 Liposarcoma 14 Lymphoma, Mantle-Cell 13 Lymphoma, Large-Cell, Anaplastic 13 Hemangiosarcoma 13 Recurrence 12 Neurofibrosarcoma 12 Leiomyosarcoma 12 Histiocytoma, Malignant Fibrous 12 Central Nervous System Neoplasms 12 Sarcoma, Synovial 11 Lymphoma, B-Cell, Marginal Zone 11

Interventions

Nivolumab 20 Ipilimumab 10 Surveys and Questionnaires 7 Paclitaxel 7 linrodostat 6 Standard of Care 6 Sirolimus 5 Gemcitabine 5 Bevacizumab 5 temsirolimus 4 relatlimab 4 Pemetrexed 4 Interviews as Topic 4 Docetaxel 4 Carboplatin 4 ARRY-334543 4 Vorinostat 3 Erlotinib Hydrochloride 3 Dasatinib 3 Cetuximab 3 regorafenib 2 olaparib 2 apatinib 2 anlotinib 2 abemaciclib 2 Trastuzumab 2 Sunitinib 2 Sorafenib 2 Olanzapine 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × Ifosfamide × Clear all

NCT00607711 2008-05-05

Study of Oral Palifosfamide Tris in Solid Tumors

Alaunos Therapeutics

Phase 1 Suspended

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡